Daniel L. Reisner

Federal Circuit Clarifies Obviousness-Type Double Patenting Rule

USPTO Issues Proposed Rule On A New Terminal Disclaimer Requirement

Patent Antibody Case Law Continues To Mature

Supreme Court Construes Key Provisions Of Biosimilar Statute

PLI Publishes Newest Edition Of Kaye Scholer's Pharma/Biotech Treatise